Search results
We conducted this review to identify published randomized controlled trials (RCTs) of cancer risk assessment tools used in primary care and to determine their impact on clinical utility (clinicians), screening uptake (patients), and psychosocial outcomes (patients).
- Breast Cancer Risk Assessment and Primary Prevention Advice in Primary ...
Within the context of implementing risk-based breast cancer...
- Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic ...
Breast cancer is currently one of the most prevalently...
- Breast Cancer Risk Assessment and Primary Prevention Advice in Primary ...
18 sie 2021 · Within the context of implementing risk-based breast cancer screening and prevention, the findings of this review suggest that primary care providers are more likely to accept an increased role in breast cancer risk assessment compared to advising on risk-reducing medications.
MNA, feasibility of chemotherapy can be predicted, and the three-item GPI may help to identify elderly cancer patients at elevated risk for mortality. Four studies tested the ability of the CGA to predict important cancer-related outcomes in specific populations.
25 sie 2021 · Breast cancer is currently one of the most prevalently diagnosed cancers and the 5th cause of cancer-related deaths with an estimated number of 2.3 million new cases worldwide according to the GLOBOCAN 2020 data [2].
PURPOSE We conducted this review to identify published randomized controlled trials (RCTs) of cancer risk assessment tools used in primary care and to deter-mine their impact on clinical utility (clinicians), screening uptake (patients), and psychosocial outcomes (patients).
1 cze 2020 · The aim of this article is to provide a stepwise approach for clinicians to assess an individual woman’s risk for breast cancer (Figure) and describe the features, appropriate use, and performance character-istics of commonly encountered risk-prediction models (Table 1).
We have developed this risk assessment tool to help primary care professionals recognise and manage the side effects of treatment in oncology and haematology patients. It will help you to support patients who are: - at risk of immunosuppression. - receiving systemic anti-cancer therapies. - undergoing radiotherapy.
